<DOC>
	<DOCNO>NCT02353858</DOCNO>
	<brief_summary>The current trial evaluate impact deep regional hyperthermia pathological complete response rate locally advance rectal cancer context preoperative 5FU base radiochemotherapy .</brief_summary>
	<brief_title>Preoperative Radiochemotherapy With Hyperthermia Locally Advanced Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Inclusion criterion : Histologically confirm Adenocarcinoma rectum ( 10 cm anal verge ) International Union Against Cancer stag II III ECOG PS 0/2 Informed consent Congestive heart failure ( NYHA III/IV ) History myocardial infarction within last 6 month . AV Block III Total hip replacement major metal pelvic implant Cardiac pacemaker Contraindications radiochemotherapy Contraindications surgical tumor resection Previous pelvic radiotherapy chemotherapy Active chronic inflammatory bowel disease Collagenosis Congenital disease increase radiosensitivity Pregnancy breastfeed Secondary malignancy locally control basalioma insitu carcinoma Infiltration anal canal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Rectal Cancer</keyword>
	<keyword>Hyperthermia</keyword>
	<keyword>Radiochemotherapy</keyword>
	<keyword>Chemoradiotherapy</keyword>
	<keyword>Deep regional hyperthermia</keyword>
	<keyword>pathologic complete response</keyword>
	<keyword>Regression Grade</keyword>
	<keyword>Locally advanced rectal cancer</keyword>
	<keyword>complete response</keyword>
</DOC>